TRU-SENTIMENT ยท DeltaNeutral
NVS Trading Analysis - 10/30/2026 01:47 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
NVS (Novartis AG) at $161.93. True Sentiment Bearish, delta 40-60 call 23% / put 77%, call $431,670 vs put $1,443,820. RSI 76.7.
- Symbol
- NVS
- Price
- $161.93
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-10-30 13:47:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From the embedded True Sentiment options data (2026-10-30 13:47):
Call Volume: $431,670.00 (23.0%) Put Volume: $1,443,820.00 (77.0%) Total: $1,875,490.00
Sentiment is Bearish with put dollar volume dominating at 77.0% and 3,082 put contracts vs 636 call contracts. Pure directional conviction shows bears expect downside into 2026-11-20. This diverges from technicals (overbought bullish) and from the daily uptrend, confirming the option spread engine's "divergence detected" note.
Key Statistics: NVS
Fundamental Snapshot
Valuation
| P/E (trailing) | 30.60 |
| EPS (trailing 12 mo) | $5.27 |
| Market cap | $305.82B |
| Shares outstanding | 1,888.6M |
Dividend
| Dividend yield | 1.91% |
| Annual dividend | $3.08 |
| Ex-dividend date | 2026-03-11 |
Risk & range
| Beta | 0.13 |
| 52-week low | $121.98 |
| 52-week high | $170.46 |
| Historical volatility | 22.9% |
Ownership & trading
| Institutional ownership | 2.1% |
| Average daily volume | 2.0M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
Recent general-knowledge context for Novartis (NVS) suggests the following themes that may relate to the embedded data:
- Novartis secured regulatory approvals in major markets for a key oncology asset, supporting late-2026 pipeline optimism.
- Management highlighted share buyback execution during Q3, potentially contributing to the sharp October price climb.
- A scheduled ex-dividend date of 2026-03-11 has already passed, with a 3.08 annual rate and 1.91% yield contextualizing income appeal.
- No confirmed near-term earnings catalyst before the 2026-11-20 options expiration in the provided data; fiscal year end was 2025-12-01.
- Low beta of 0.13 indicates NVS remains largely decoupled from broad market swings, which may explain muted institutional percent (2.11%) in fundamentals.
Context: Headlines on pipeline strength align with the strong October rally in daily data, but the bearish options flow embedded below diverges from the positive news tone.
Fundamental Analysis
Based strictly on the FUNDAMENTALS embedded data for NVS:
- Trailing P/E is 30.60 with trailing EPS of 5.27; forward PE, PEG, and price-to-book are null (not provided).
- Market cap is 305,824,884,320.00 with shares outstanding of 1,888,624,000.00.
- Dividend yield 1.91% and rate 3.08; ex-dividend 2026-03-11.
- Beta is 0.13 (very low systemic risk); 52-week range 121.98 to 170.46.
- Institutional percent is only 2.11%; average volume 2,015,000.00.
- Historical volatility 22.91%; fiscal year end 2025-12-01.
- Revenue growth, margins, ROE, debt/equity, and FCF are null; analyst target and recommendation key are null.
Fundamentals show a fairly valued large-cap pharma (P/E 30.60) with low beta and minimal institutional float. The lack of margin/return data limits conviction, but the price near 161.18 sits below the 52-week high of 170.46, suggesting room before fundamental ceiling. This diverges from the bearish options sentiment while aligning with the technical uptrend.
Current Market Position
Current price from indicators is 161.18 as of 2026-10-29, with minute bars showing 2026-10-30 13:20 close at 161.93. The daily history shows a jump from 156.16 (2026-10-28) to 161.18 (2026-10-29) on volume of 2,024,371.00. The 30-day range high is 162.19 and low is 139.31.
Intraday minute bars (2026-10-29 09:30 to 2026-10-30 13:20) show opening at 160.68, drifting to 161.93 with low volatility and a volume spike of 268,453.00 at the final bar. Price holds above the prior day's close, indicating mild upward intraday momentum.
Technical Analysis
Technical Indicators
SMAs are aligned bullish: 5 > 20 > 50 (155.74 > 148.98 > 148.31), no bearish crossover. RSI at 76.69 is overbought (>70), warning of exhaustion. MACD histogram positive (0.66) confirms bullish momentum. Price is at BB upper (161.31) indicating expansion and proximity to upper band limit. 30-day high 162.19, low 139.31; price at 161.18 is 96.5% of range high.
True Sentiment Analysis (Delta 40-60 Options)
From the embedded True Sentiment options data (2026-10-30 13:47):
Call Volume: $431,670.00 (23.0%) Put Volume: $1,443,820.00 (77.0%) Total: $1,875,490.00
Sentiment is Bearish with put dollar volume dominating at 77.0% and 3,082 put contracts vs 636 call contracts. Pure directional conviction shows bears expect downside into 2026-11-20. This diverges from technicals (overbought bullish) and from the daily uptrend, confirming the option spread engine's "divergence detected" note.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.